Cart summary

You have no items in your shopping cart.

ARCC-4

ARCC-4

Catalog Number: orb1989542

DispatchUsually dispatched within 5-10 working days
Contact us for a quotation
Catalog Numberorb1989542
CategorySmall Molecules
DescriptionARCC-4 is an enzalutamide-based von Hippel-Lindau (VHL)-recruiting AR PROTAC and outperforms enzalutamide and it is a low-nanomolar androgen receptor (AR) degrader based on PROTAC, with a DC50 of 5 nM. ARCC-4 effectively degrades clinically relevant AR mutants associated with antiandrogen therapy[1].
CAS Number1973403-00-7
Purity98.00%
MW1024.18
SMILESCc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCCCOc2ccc(cc2)-c2ccc(cc2)N2C(=S)N(C(=O)C2(C)C)c2ccc(C#N)c(c2)C(F)(F)F)C(C)(C)C)cc1
FormulaC53H56F3N7O7S2
Biological ActivityARCC-4 is an enzalutamide-based von Hippel-Lindau (VHL)-recruiting AR PROTAC and outperforms enzalutamide and it is a low-nanomolar androgen receptor (AR) degrader based on PROTAC, with a DC50 of 5 nM. ARCC-4 effectively degrades clinically relevant AR mutants associated with antiandrogen therapy[1].
Storage-20°C
NoteFor research use only
Expiration Date12 months from date of receipt.
  • ARCC 4 negative control [orb1690053]

    98%

    2156588-26-8

    1024.19

    C53H56F3N7O7S2

    5 mg